Table 2.
Comparison of intraoperative end-tidal desflurane concentration and BIS during three phases of live-donor liver transplant
| Baseline | Dissection phase (DP) % | Anhepatic phase (AP) % | Neohepatic phase (NP) % |
P |
|||||
|---|---|---|---|---|---|---|---|---|---|
| DP v/s AP | DP v/s NP | AP v/s NP | Overall | ||||||
| Overall (n=40) | Et-Des | - | 2.92±0.65 | 2.68±0.85 | 2.58±0.71 | 0.049 | 0.005 | 0.93 | 0.87 |
| BIS | 96.20±1.71 | 51.10±5.95 | 45.01±4.39 | 45.73±4.10 | 0.001 | 0.001 | 0.52 | 0.001 | |
| MELD <20 (n=24) | Et-Des | - | 3.11±0.49 | 2.96±0.76 | 2.72±0.57 | 0.54 | 0.004 | 0.28 | 0.24 |
| BIS | 95.85±1.69 | 50.54±3.86 | 45.09±3.94 | 45.93±3.67 | 0.001 | 0.001 | 0.78 | 0.005 | |
| MELD ≥20 (n=16) | Et-Des | - | 2.58±0.77 | 2.17±0.79 | 2.32±0.87 | 0.13 | 0.74 | 0.74 | 0.05 |
| BIS | 96.86±1.61 | 52.14±8.70 | 44.86±5.30 | 45.37±3.93 | 0.008 | 0.02 | >0.99 | 0.001 | |
MELD – Model for End -stage Liver Disease; Et-Des – End-tidal desflurane concentration, Values expressed as mean±S.D, P<0.05 significant